A little-known warning sign of a potentially life-threatening condition could appear on your pillowcases and bed linen come ...

At the recent American Society of Hematology (ASH) annual meeting, phase II data were presented on a bispecific antibody for ...

The FDA granted accelerated approval to Lunsumio VELO for adults with relapsed/refractory follicular lymphoma after two or ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

The gymnastics world is in mourning after the death of Isabelle Marciniak. The former Brazilian junior all-around champion ...

First-line treatment selection in follicular lymphoma is closely tied to tumor stage, disease burden, and patient-specific ...

Ms Smith took the decision not to have breast reconstruction because it would have significantly extended her recovery time, ...

Miami Hurricanes basketball player Marcus Allen is out for the year after being diagnosed with non-Hodgkin lymphoma -- a form ...

Trial sponsors are typically responsible for providing the experimental drug or treatment at no cost to patients. However, ...

Students at the University of Nebraska-Lincoln have created a pilot program for the Lymphoma Research Foundation they hope will raise awareness about the disease among young adults. They are trying to ...

Three years after its initial FDA approval, Roche has made up for an early disadvantage with its blood cancer drug Lunsumio ...